The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling

The determination of animal form depends on the coordination of events that lead to the morphological patterning of cells. This epigenetic view of development suggests that embryonic structures arise as a consequence of environmental influences acting on the properties of cells, rather than an unfolding of a completely genetically specified and preexisting invisible pattern. Specialized cells of developing multicellular organisms are surrounded by a complex extracellular matrix (ECM), comprised largely of different collagens, proteoglycans, and glycoproteins. This ECM is a substrate for tissue morphogenesis, lends support and flexibility to mature tissues, and acts as an epigenetic informational entity in the sense that it transduces and integrates intracellular signals via distinct cell surface receptors. Consequently, ECM‐receptor interactions have a profound influence on major cellular programs including growth, differentiation, migration, and survival. In contrast to many other ECM proteins, the tenascin (TN) family of glycoproteins (TN‐C, TN‐R, TN‐W, TN‐X, and TN‐Y) display highly restricted and dynamic patterns of expression in the embryo, particularly during neural development, skeletogenesis, and vasculogenesis. These molecules are reexpressed in the adult during normal processes such as wound healing, nerve regeneration, and tissue involution, and in pathological states including vascular disease, tumorigenesis, and metastasis. In concert with a multitude of associated ECM proteins and cell surface receptors that include members of the integrin family, TN proteins impart contrary cellular functions, depending on their mode of presentation (i.e., soluble or substrate‐bound) and the cell types and differentiation states of the target tissues. Expression of tenascins is regulated by a variety of growth factors, cytokines, vasoactive peptides, ECM proteins, and biomechanical factors. The signals generated by these factors converge on particular combinations of cis‐regulatory elements within the recently identified TN gene promoters via specific transcriptional activators or repressors. Additional complexity in regulating TN gene expression is achieved through alternative splicing, resulting in variants of TN polypeptides that exhibit different combinations of functional protein domains. In this review, we discuss some of the recent advances in TN biology that provide insights into the complex way in which the ECM is regulated and how it functions to regulate tissue morphogenesis and gene expression. Dev Dyn;218:235–259. © 2000 Wiley‐Liss, Inc.

[1]  J. Isola,et al.  Mechanical loading regulates tenascin-C expression in the osteotendinous junction. , 1999, Journal of cell science.

[2]  H. Moch,et al.  Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer. , 1993, Pathology, research and practice.

[3]  R. Doolittle,et al.  Presence of a vertebrate fibrinogen-like sequence in an echinoderm. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Kleinman,et al.  Thymosin β4 Accelerates Wound Healing , 1999 .

[5]  J. Paulson,et al.  Complete primary structure of porcine tenascin. Detection of tenascin transcripts in adult submaxillary glands. , 1991, European journal of biochemistry.

[6]  H. Erickson,et al.  Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. , 1989, Annual review of cell biology.

[7]  A. Faissner,et al.  Evidence for Combinatorial Variability of Tenascin-C Isoforms and Developmental Regulation in the Mouse Central Nervous System* , 1999, The Journal of Biological Chemistry.

[8]  Andres F. Oberhauser,et al.  The molecular elasticity of the extracellular matrix protein tenascin , 1998, Nature.

[9]  R. Falchetto,et al.  Neuronal cell adhesion molecule contactin/F11 binds to tenascin via its immunoglobulin-like domains , 1992, The Journal of cell biology.

[10]  G. Edelman,et al.  Functional mapping of cytotactin: proteolytic fragments active in cell- substrate adhesion , 1988, The Journal of cell biology.

[11]  A. Skubitz,et al.  Tenascin-R (J1 160/180 inhibits fibronectin-mediated cell adhesion--functional relatedness to tenascin-C. , 1994, Journal of cell science.

[12]  G M Edelman,et al.  A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  K. Crossin,et al.  Cytotactin binding: inhibition of stimulated proliferation and intracellular alkalinization in fibroblasts. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Ruoslahti,et al.  The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Probstmeier,et al.  Tenascin-C inhibits beta1 integrin-dependent cell adhesion and neurite outgrowth on fibronectin by a disialoganglioside-mediated signaling mechanism. , 1999, Glycobiology.

[16]  L. Zardi,et al.  The first untranslated exon of the human tenascin‐C gene plays a regulatory role in gene transcription , 1995, FEBS letters.

[17]  B. Imhof,et al.  Tenascin Mr 220,000 isoform expression correlates with corneal cell migration. , 1991, Development.

[18]  M. Humphries,et al.  Effects of collagenase-cleavage of type I collagen on alpha2beta1 integrin-mediated cell adhesion. , 1998, Journal of cell science.

[19]  C. Lethias,et al.  Characterization of the Bovine Tenascin-X* , 1997, The Journal of Biological Chemistry.

[20]  F. D. De Braud,et al.  Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin , 1999, European Journal of Nuclear Medicine.

[21]  R. Kretsinger,et al.  Troponin and parvalbumin calcium binding regions predicted in myosin light chain and T4 lysozyme. , 1975, Science.

[22]  Shigeki,et al.  Tenascin: cDNA cloning and induction by TGF‐beta. , 1988, The EMBO journal.

[23]  K. Crossin,et al.  Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin , 1992, The Journal of cell biology.

[24]  H. Erickson,et al.  A six-armed oligomer isolated from cell surface fibronectin preparations , 1984, Nature.

[25]  H. Erickson,et al.  Pervasive conformational fluctuations on microsecond time scales in a fibronectin type III domain , 1998, Nature Structural Biology.

[26]  J. Spring,et al.  Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue , 1996, The Journal of cell biology.

[27]  L. Patthy Homology of a domain of the growth hormone/prolactin receptor family with type III modules of fibronectin , 1990, Cell.

[28]  M. Bottazzi,et al.  Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. , 1999, Molecular biology of the cell.

[29]  D. Zagzag,et al.  Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. , 1996, Cancer research.

[30]  P. Jones,et al.  Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. , 1997, The American journal of pathology.

[31]  M. Bissell,et al.  Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity , 1991, The Journal of cell biology.

[32]  V. Quaranta,et al.  Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules. , 1991, The American journal of pathology.

[33]  D. Bigner,et al.  Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. , 1983, Cancer research.

[34]  D. Taverna,et al.  Laminin and tenascin assembly and expression regulate HC11 mouse mammary cell differentiation. , 1994, Journal of cell science.

[35]  Z. Werb,et al.  Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution , 1992, The Journal of cell biology.

[36]  M. Schachner,et al.  Zebrafish tenascin-W, a new member of the tenascin family. , 1998, Journal of neurobiology.

[37]  L. Zardi,et al.  The Alternative Splicing Pattern of the Tenascin-C Pre-mRNA Is Controlled by the Extracellular pH (*) , 1995, The Journal of Biological Chemistry.

[38]  R. Coleman,et al.  Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  A. Bartolazzi,et al.  Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression. , 1993, International journal of cancer.

[40]  R. Kammerer,et al.  Tenascin-C Hexabrachion Assembly Is a Sequential Two-step Process Initiated by Coiled-coil α-Helices* , 1998, The Journal of Biological Chemistry.

[41]  H. Birkedal‐Hansen Proteolytic remodeling of extracellular matrix. , 1995, Current opinion in cell biology.

[42]  R. Tucker,et al.  Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. , 1992, Journal of cell science.

[43]  M. Schachner,et al.  High Affinity Binding and Overlapping Localization of Neurocan and Phosphacan/Protein-tyrosine Phosphatase-ζ/β with Tenascin-R, Amphoterin, and the Heparin-binding Growth-associated Molecule* , 1998, The Journal of Biological Chemistry.

[44]  W A Hendrickson,et al.  Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. , 1992, Science.

[45]  H. Erickson,et al.  Tenascin is induced at implantation sites in the mouse uterus and interferes with epithelial cell adhesion. , 1994, Development.

[46]  D. Sheppard,et al.  The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin. , 1995, The Journal of biological chemistry.

[47]  M. Schwab,et al.  Identification of a cDNA clone specific for the oligodendrocyte‐derived repulsive extracellular matrix molecule J1‐160/180 , 1991, Journal of neuroscience research.

[48]  V. Sukhatme,et al.  Rapid induction and translocation of Egr-1 in response to mechanical strain in vascular smooth muscle cells. , 1999, Circulation research.

[49]  M. Brown-Luedi,et al.  Tenascin-Y, a component of distinctive connective tissues, supports muscle cell growth. , 1999, Experimental cell research.

[50]  C. Rüegg,et al.  Tenascin‐C inhibits β1 integrin‐dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1 – 5 repeats to fibronectin , 1999, European journal of immunology.

[51]  J. Spring,et al.  Tenascin-C expression by fibroblasts is elevated in stressed collagen gels , 1994, The Journal of cell biology.

[52]  R. Tucker,et al.  The tenascin-C knockout revisited. , 1999, Journal of cell science.

[53]  I. Campbell,et al.  The first EGF‐like domain from human factor IX contains a high‐affinity calcium binding site. , 1990, EMBO Journal.

[54]  MHox and vertebrate skeletogenesis: the long and the short of it. , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[55]  J. Spring,et al.  Two contrary functions of tenascin: Dissection of the active sites by recombinant tenascin fragments , 1989, Cell.

[56]  H. Erickson,et al.  Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C , 1994, The Journal of cell biology.

[57]  M J Bissell,et al.  Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  B. Franza,et al.  Fos and jun: The AP-1 connection , 1988, Cell.

[59]  K. Crossin Functional role of cytotactin/tenascin in morphogenesis: a modest proposal. , 1994, Perspectives on developmental neurobiology.

[60]  H. M. Geller,et al.  Long and Short Splice Variants of Human Tenascin Differentially Regulate Neurite Outgrowth , 1997, Molecular and Cellular Neuroscience.

[61]  M. Fishbein,et al.  Arterialization of human vein grafts is associated with tenascin-C expression. , 1999, Journal of the American College of Cardiology.

[62]  L. Zardi,et al.  Different Susceptibility of Small and Large Human Tenascin-C Isoforms to Degradation by Matrix Metalloproteinases (*) , 1995, The Journal of Biological Chemistry.

[63]  R. Gandour-Edwards,et al.  The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species. , 1997, Differentiation; research in biological diversity.

[64]  S. Baumgartner,et al.  Tena , a Drosophila gene related to tenascin, shows selective transcript localization , 1993, Mechanisms of Development.

[65]  Y Ikawa,et al.  Mice develop normally without tenascin. , 1992, Genes & development.

[66]  A. Mikos,et al.  Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. , 1997, Journal of biomedical materials research.

[67]  H. Erickson,et al.  Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. , 1994, Journal of cell science.

[68]  K. Gooch,et al.  Mechanical Forces: Their Effects on Cells and Tissues , 1997, Biotechnology Intelligence Unit.

[69]  W. Miller,et al.  Alternate promoters and alternate splicing of human tenascin-X, a gene with 5' and 3' ends buried in other genes. , 1996, Human molecular genetics.

[70]  M J Bissell,et al.  Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. , 1989, Development.

[71]  John P. Geibel,et al.  Cyclic strain induces reorganization of integrin α5β1 and α2β1 in human umbilical vein endothelial cells , 1997 .

[72]  T. Collins,et al.  Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[73]  S. Schenk,et al.  The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation. , 1999, Molecular biology of the cell.

[74]  L. Zardi,et al.  Structure of 5' region of human tenascin-R gene and characterization of its promoter. , 1998, DNA and cell biology.

[75]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[76]  T. R. Welch,et al.  Modular Variations of the Human Major Histocompatibility Complex Class III Genes for Serine/Threonine Kinase RP, Complement Component C4, Steroid 21-Hydroxylase CYP21, and Tenascin TNX (the RCCX Module) , 1999, The Journal of Biological Chemistry.

[77]  Z. Werb,et al.  The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. , 1994, Molecular biology of the cell.

[78]  M. Kusakabe,et al.  Reduced mRNA expression of neuropeptide Y in the limbic system of tenascin gene disrupted mouse brain , 1998, Neuropeptides.

[79]  M. Schachner,et al.  The peripheral nerve and the neuromuscular junction are affected in the tenascin-C-deficient mouse. , 1998, Cellular and molecular biology.

[80]  W. Göhring,et al.  Analysis of Neurocan Structures Interacting with the Neural Cell Adhesion Molecule N-CAM* , 1996, The Journal of Biological Chemistry.

[81]  A. Bartolazzi,et al.  Integrin expression in cutaneous malignant melanoma: Association of the α3/β1 heterodimer with tumor progression , 1993 .

[82]  M. Bissell,et al.  Extracellular matrix and hormones transcriptionally regulate bovine beta-casein 5' sequences in stably transfected mouse mammary cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[83]  J. Bristow,et al.  Tenascin–X deficiency is associated with Ehlers–Danlos syndrome , 1997, Nature Genetics.

[84]  J. Eisman,et al.  rHox: A homeobox gene expressed in osteoblastic cells , 1995, Journal of cellular biochemistry.

[85]  W. Hurley Mammary gland function during involution. , 1989, Journal of dairy science.

[86]  S. Werner,et al.  Skin wounds and severed nerves heal normally in mice lacking tenascin-C. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[87]  E. Olson,et al.  MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer. , 1992, Development.

[88]  R. Derynck,et al.  Extracellular matrix regulates expression of the TGF-beta 1 gene , 1993, The Journal of cell biology.

[89]  E. White,et al.  Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.

[90]  P. Ekblom,et al.  Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions. , 1989, The International journal of developmental biology.

[91]  L. Vaughan,et al.  Tenascin-contactin/F11 interactions: a clue for a developmental role? , 1994, Perspectives on developmental neurobiology.

[92]  S. Baumgartner,et al.  Tenm, a Drosophila gene related to tenascin, is a new pair‐rule gene. , 1994, The EMBO journal.

[93]  Z. Werb,et al.  Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. , 1996, Current opinion in cell biology.

[94]  R. Kosaki,et al.  Immunohistochemical evidence for the brevican‐tenascin‐R interaction: Colocalization in perineuronal nets suggests a physiological role for the interaction in the adult rat brain , 1999, The Journal of comparative neurology.

[95]  F. Viti,et al.  The human homeodomain protein OTX2 binds to the human tenascin-C promoter and trans-represses its activity in transfected cells. , 1997, DNA and cell biology.

[96]  H. Erickson,et al.  Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin α8β1 receptor interactions with tenascin: Murine α8β1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C , 1998 .

[97]  M. Bissell,et al.  Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells. Localization of active regions using recombinant tenascin fragments. , 1995, Journal of cell science.

[98]  C. Streuli,et al.  Extracellular matrix remodelling and cellular differentiation. , 1999, Current opinion in cell biology.

[99]  C. Lethias,et al.  Cell adhesion to tenascin-X mapping of cell adhesion sites and identification of integrin receptors. , 1999, European journal of biochemistry.

[100]  R. D. de Jong,et al.  DNA-binding specificity of the S8 homeodomain. , 1993, Nucleic acids research.

[101]  S. Gitelman,et al.  Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[102]  G. Edelman,et al.  Differential effects of cytotactin/tenascin fusion proteins on intracellular pH and cell morphology , 1994, Journal of cellular physiology.

[103]  M. Chiquet,et al.  Regulation of extracellular matrix gene expression by mechanical stress. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[104]  G. Edelman,et al.  Asymmetric expression in somites of cytotactin and its proteoglycan ligand is correlated with neural crest cell distribution. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[105]  D. Taylor,et al.  Alternatively spliced tenascin-C mRNA isoforms in human fetal membranes. , 1999, Molecular human reproduction.

[106]  N. Nakao,et al.  Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. , 1998, The American journal of pathology.

[107]  R. Chiquet‐Ehrismann,et al.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.

[108]  M. DeRuiter,et al.  Patterns of paired‐related homeobox genes PRX1 and PRX2 suggest involvement in matrix modulation in the developing chick vascular system , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[109]  T. Triche,et al.  Stimulation of human neuronectin secretion by brain-derived growth factors , 1989, Brain Research.

[110]  H. M. Geller,et al.  Tenascin-C Contains Domains That Independently Regulate Neurite Outgrowth and Neurite Guidance , 1999, The Journal of Neuroscience.

[111]  P. Maurel,et al.  TAG-1/Axonin-1 Is a High-affinity Ligand of Neurocan, Phosphacan/Protein-tyrosine Phosphatase-ζ/β, and N-CAM* , 1996, The Journal of Biological Chemistry.

[112]  H. Kleinman,et al.  Thymosin beta4 accelerates wound healing. , 1999, The Journal of investigative dermatology.

[113]  H. Erickson,et al.  Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. , 1996, Molecular biology of the cell.

[114]  M. Bissell,et al.  A novel transcriptional enhancer is involved in the prolactin- and extracellular matrix-dependent regulation of beta-casein gene expression. , 1992, Molecular biology of the cell.

[115]  L. Lanyon,et al.  Expression of Tenascin‐C in Bones Responding to Mechanical Load , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[116]  L. Zardi,et al.  Cell-cycle dependent alternative splicing of the tenascin primary transcript. , 1994, Cell adhesion and communication.

[117]  M. Rabinovitch,et al.  Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. , 1996, Circulation research.

[118]  M. Götz,et al.  Tenascin‐C Synthesis and Influence on Axonal Growth During Rat Cortical Development , 1997, The European journal of neuroscience.

[119]  P. Ekblom,et al.  Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis , 1991, The Journal of cell biology.

[120]  T. Sakakura New aspects of stroma-parenchyma relations in mammary gland differentiation. , 1991, International review of cytology.

[121]  T. Brümmendorf,et al.  Neural cell recognition molecule F11: Homology with fibronectin type III and immunoglobulin type C domains , 1989, Neuron.

[122]  H. Erickson,et al.  Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin alpha 8 beta 1 receptor interactions with tenascin: murine alpha 8 beta 1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C. , 1998, Biochemistry.

[123]  G. Panayotou,et al.  Tenascin: a modulator of cell growth. , 1992, European journal of biochemistry.

[124]  K. Naruse,et al.  Up-regulation of integrin beta 3 expression by cyclic stretch in human umbilical endothelial cells. , 1997, Biochemical and biophysical research communications.

[125]  E. Spiess,et al.  Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons , 1996, The Journal of cell biology.

[126]  D. Steindler,et al.  Tenascin‐C knockout mouse has no detectable tenascin‐C protein , 1997, Journal of neuroscience research.

[127]  J. Martín,et al.  prx-1 functions cooperatively with another paired-related homeobox gene, prx-2, to maintain cell fates within the craniofacial mesenchyme. , 1999, Development.

[128]  N. Mataga,et al.  Tyrosine hydroxylase activity and its mRNA level in dopaminergic neurons of tenascin gene knockout mouse. , 1997, Biochemical and biophysical research communications.

[129]  R. Fässler,et al.  Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts , 1993, The Journal of cell biology.

[130]  S. Ayad,et al.  Conformation dependence of integrin-type II collagen binding. Inability of collagen peptides to support alpha 2 beta 1 binding, and mediation of adhesion to denatured collagen by a novel alpha 5 beta 1-fibronectin bridge. , 1994, Journal of cell science.

[131]  M. Reidy,et al.  Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. , 1994, Circulation research.

[132]  G. Edelman,et al.  A detailed structural model of cytotactin: protein homologies, alternative RNA splicing, and binding regions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[133]  M J Bissell,et al.  Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma. , 1995, Journal of cell science.

[134]  T. Ikemura,et al.  Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family. , 1998, Gene.

[135]  Adriana C. Gittenberger-de Groot,et al.  Expression patterns of the paired-related homeobox genes MHox/Prx1 and S8/Prx2 suggest roles in development of the heart and the forebrain , 1995, Mechanisms of Development.

[136]  Z. Werb,et al.  Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[137]  G M Rubin,et al.  Spacing differentiation in the developing Drosophila eye: a fibrinogen-related lateral inhibitor encoded by scabrous. , 1990, Science.

[138]  M. Schachner,et al.  Signaling events following the interaction of the neuronal adhesion molecule F3 with the N‐terminal domain of tenascin‐R , 1997, Journal of neuroscience research.

[139]  G. Edelman,et al.  Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[140]  M. Schachner,et al.  Detection of tenascin‐C in the nervous system of the tenascin‐C mutant mouse , 1995, Journal of neuroscience research.

[141]  B. Sumpio,et al.  Cyclic strain induces reorganization of integrin alpha 5 beta 1 and alpha 2 beta 1 in human umbilical vein endothelial cells. , 1997, Journal of cellular biochemistry.

[142]  T. Jessell,et al.  Spatial regulation of axonal glycoprotein expression on subsets of embryonic spinal neurons , 1988, Neuron.

[143]  T. Ikemura,et al.  The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C , 1994, The Journal of cell biology.

[144]  A. Canfield,et al.  Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. , 1995, Journal of cell science.

[145]  R. Gherzi,et al.  Human Tenascin Gene , 1995, The Journal of Biological Chemistry.

[146]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[147]  I. Virtanen,et al.  Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[148]  J. Gulcher,et al.  An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[149]  R. Doolittle Fibrinogen and fibrin. , 1981, Scientific American.

[150]  J. Garrido,et al.  Distinct tissue distribution in pigs of tenascin-X and tenascin-C transcripts. , 1995, European journal of biochemistry.

[151]  A. Desmoulière,et al.  Mechanical forces induce scar remodeling. Study in non-pressure-treated versus pressure-treated hypertrophic scars. , 1999, The American journal of pathology.

[152]  P. Sonderegger,et al.  Discrete clusters of axonin-1 and NgCAM at neuronal contact sites: facts and speculations on the regulation of axonal fasciculation. , 1998, Progress in brain research.

[153]  George E. Davis,et al.  Affinity of integrins for damaged extracellular matrix: αvβ3 binds to denatured collagen type I through RGD sites , 1992 .

[154]  H. Erickson,et al.  Backbone dynamics of homologous fibronectin type III cell adhesion domains from fibronectin and tenascin. , 1997, Structure.

[155]  P. Vernier,et al.  The c-Jun-induced transformation process involves complex regulation of tenascin-C expression , 1997, Molecular and cellular biology.

[156]  P. Sriramarao,et al.  A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices , 1993, Nucleic Acids Res..

[157]  G. Edelman,et al.  Identification and characterization of the promoter for the cytotactin gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[158]  T. Sakakura,et al.  Persistence of responsiveness of adult mouse mammary gland to induction by embryonic mesenchyme. , 1979, Developmental biology.

[159]  I. Campbell,et al.  The solution structure of human epidermal growth factor , 1987, Nature.

[160]  M. Kusakabe,et al.  Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. , 1988, Developmental biology.

[161]  D. Friedlander,et al.  Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules , 1994, The Journal of cell biology.

[162]  M. Schachner,et al.  Tenascin mRNA isoforms in the developing mouse brain , 1994, Journal of neuroscience research.

[163]  J. Spring,et al.  Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. , 1991, Cell regulation.

[164]  M. Schachner,et al.  Tenascin and extracellular matrix glycoproteins: from promotion to polarization of neurite growth in vitro , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[165]  F. Viti,et al.  The Human Tenascin-R Gene* , 1996, The Journal of Biological Chemistry.

[166]  G. Edelman,et al.  Molecular forms, binding functions, and developmental expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules , 1988, The Journal of cell biology.

[167]  H. Erickson,et al.  Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. , 1993, The Journal of biological chemistry.

[168]  D A Parry,et al.  Three-stranded alpha-fibrous proteins: the heptad repeat and its implications for structure. , 1991, International journal of biological macromolecules.

[169]  M. Chiquet,et al.  Regulation of extracellular matrix synthesis by mechanical stress. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[170]  J. Couso,et al.  Composite signalling from Serrate and Delta establishes leg segments in Drosophila through Notch. , 1999, Development.

[171]  C. S. Chen,et al.  Geometric control of cell life and death. , 1997, Science.

[172]  Y. Okada,et al.  Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases , 1994, FEBS letters.

[173]  A. Howell,et al.  Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma. , 1990, Differentiation; research in biological diversity.

[174]  U. Hedin,et al.  Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype. , 1991, The American journal of pathology.

[175]  Z. Werb,et al.  Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. , 1991, Development.

[176]  M. Schwartz,et al.  Focal Adhesion Kinase Mediates the Integrin Signaling Requirement for Growth Factor Activation of Map Kinase , 1999, The Journal of cell biology.

[177]  R. Timpl,et al.  Fibulin-1 Is a Ligand for the C-type Lectin Domains of Aggrecan and Versican* , 1999, The Journal of Biological Chemistry.

[178]  Z. Werb,et al.  Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752] , 1994, The Journal of cell biology.

[179]  M. Chiquet,et al.  Dual function of tenascin: simultaneous promotion of neurite growth and inhibition of glial migration. , 1993, Journal of cell science.

[180]  S. Baumgartner,et al.  Teneurin-1, a vertebrate homologue of the Drosophila pair-rule gene ten-m, is a neuronal protein with a novel type of heparin-binding domain. , 1999, Journal of cell science.

[181]  M. Berens,et al.  Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. , 1996, Journal of cell science.

[182]  S. Gitelman,et al.  Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B , 1993, The Journal of cell biology.

[183]  G. Edelman,et al.  Localization during development of alternatively spliced forms of cytotactin mRNA by in situ hybridization , 1990, The Journal of cell biology.

[184]  C. Lethias,et al.  Flexilin: a new extracellular matrix glycoprotein localized on collagen fibrils. , 1996, Matrix biology : journal of the International Society for Matrix Biology.

[185]  D. Schuster,et al.  The role of vascular injury and hemodynamics in rat pulmonary artery remodeling. , 1996, The Journal of clinical investigation.

[186]  F. Rathjen,et al.  Functional Interactions of the Immunoglobulin Superfamily Member F11 Are Differentially Regulated by the Extracellular Matrix Proteins Tenascin-R and Tenascin-C* , 1999, The Journal of Biological Chemistry.

[187]  R. Fässler,et al.  Mapping of a Defined Neurocan Binding Site to Distinct Domains of Tenascin-C* , 1997, The Journal of Biological Chemistry.

[188]  N. Mataga,et al.  Abnormal behavior and neurotransmissions of tenascin gene knockout mouse. , 1996, Biochemical and biophysical research communications.

[189]  P. Altevogt,et al.  Integrin and Neurocan Binding to L1 Involves Distinct Ig Domains* , 1999, The Journal of Biological Chemistry.

[190]  M. Ferguson,et al.  The extracellular matrix of lip wounds in fetal, neonatal and adult mice. , 1991, Development.

[191]  T. Schulthess,et al.  The Fibrinogen-like Globe of Tenascin-C Mediates Its Interactions with Neurocan and Phosphacan/Protein-tyrosine Phosphatase-ζ/β* , 1997, The Journal of Biological Chemistry.

[192]  E. Mackie,et al.  Modulation of osteoblast behaviour by tenascin. , 1996, Journal of cell science.

[193]  P. Jones,et al.  Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. , 2000, The Journal of clinical investigation.

[194]  C. Rüegg,et al.  Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. , 1997, Journal of immunology.

[195]  Timo Sorsa,et al.  Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.

[196]  F. Rathjen,et al.  Dissection of Complex Molecular Interactions of Neurofascin with Axonin-1, F11, and Tenascin-R, Which Promote Attachment and Neurite Formation of Tectal Cells , 1998, The Journal of cell biology.

[197]  I. Thesleff,et al.  Syndecan from embryonic tooth mesenchyme binds tenascin. , 1989, The Journal of biological chemistry.

[198]  L. Zardi,et al.  Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[199]  M. Bedolli,et al.  Embryonic expression of tenascin‐X suggests a role in limb, muscle, and heart development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[200]  C Grobstein,et al.  Mechanisms of organogenetic tissue interaction. , 1967, National Cancer Institute monograph.

[201]  M J Bissell,et al.  Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. , 1998, The American journal of pathology.

[202]  I. Thesleff,et al.  Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro , 1987, The Journal of cell biology.

[203]  H. Erickson,et al.  Gene knockouts of c-src, transforming growth factor beta 1, and tenascin suggest superfluous, nonfunctional expression of proteins , 1993, The Journal of cell biology.

[204]  S. Young,et al.  TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung. , 1995, The American journal of physiology.

[205]  R. Strange,et al.  Apoptotic cell death and tissue remodelling during mouse mammary gland involution. , 1992, Development.

[206]  J. Schlessinger,et al.  Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin. , 1994, The Journal of biological chemistry.

[207]  H. Hsieh,et al.  Modulation of Ras/Raf/extracellular signal-regulated kinase pathway by reactive oxygen species is involved in cyclic strain-induced early growth response-1 gene expression in endothelial cells. , 1999, Circulation research.

[208]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[209]  I. Thesleff,et al.  Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme , 1989, The Journal of cell biology.

[210]  G. Davis,et al.  Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites. , 1992, Biochemical and biophysical research communications.

[211]  M. Neville,et al.  The Mammary gland : development, regulation, and function , 1987 .

[212]  M. Schachner,et al.  Distinct Effects of Recombinant Tenascin‐R Domains in Neuronal Cell Functions and Identification of the Domain Interacting with the Neuronal Recognition Molecule F3/11 , 1996, The European journal of neuroscience.

[213]  R. U. Margolis,et al.  Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. , 1994, The Journal of biological chemistry.

[214]  W. Muller,et al.  Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer. , 1999, Journal of cell science.

[215]  R. Chiquet‐Ehrismann,et al.  Restrictin: a chick neural extracellular matrix protein involved in cell attachment co-purifies with the cell recognition molecule F11. , 1991, Development.

[216]  S. Dunnett,et al.  Myelination and behaviour of tenascin‐C null transgenic mice , 1999, The European journal of neuroscience.

[217]  P. Jones,et al.  Regulation of Tenascin-C, a Vascular Smooth Muscle Cell Survival Factor that Interacts with the αvβ3 Integrin to Promote Epidermal Growth Factor Receptor Phosphorylation and Growth , 1997, The Journal of cell biology.

[218]  U. Lendahl A growing family of Notch ligands. , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[219]  K. Winterhalter,et al.  Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin , 1996, FEBS letters.

[220]  L. Vaughan,et al.  Contactin/F11 and tenascin-C co-expression in the chick retina correlates with formation of the synaptic plexiform layers. , 1995, Current eye research.

[221]  M. Chiquet,et al.  A Single Heparin Binding Region within the Fibrinogen-like Domain Is Functional in Chick Tenascin-C (*) , 1995, The Journal of Biological Chemistry.

[222]  I. Thesleff,et al.  Changes in the distribution of tenascin during tooth development. , 1987, Development.

[223]  O. Ruuskanen,et al.  Homozygous deletion of the CYP21A-TNXA-RP2-C4B gene region conferring C4B deficiency associated with recurrent respiratory infections. , 1999, Human immunology.

[224]  TENASCIN EXPRESSION DURING WOUND HEALING IN HUMAN SKIN , 1996, The Journal of pathology.

[225]  P. Cooke,et al.  Stromal-epithelial interactions in adult organs. , 1985, Cell differentiation.

[226]  R. Assoian,et al.  Integrin-dependent activation of MAP kinase: a link to shape-dependent cell proliferation. , 1995, Molecular biology of the cell.

[227]  P. Jones,et al.  Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. , 1999, Circulation research.

[228]  R. Timpl,et al.  The J1 glycoprotein—a novel nervous system cell adhesion molecule of the L2/HNK-1 family , 1985, Nature.

[229]  M. Rabinovitch,et al.  Induction of vascular smooth muscle cell tenascin-C gene expression by denatured type I collagen is dependent upon a beta3 integrin-mediated mitogen-activated protein kinase pathway and a 122-base pair promoter element. , 1999, Journal of cell science.

[230]  R. Wides,et al.  odd Oz: A novel Drosophila pair rule gene , 1994, Cell.

[231]  J. Sanes,et al.  Organization and Reorganization of Neuromuscular Junctions in Mice Lacking Neural Cell Adhesion Molecule, Tenascin-C, or Fibroblast Growth Factor-5 , 1998, The Journal of Neuroscience.

[232]  D. Sheppard,et al.  The Human Integrin α8β1 Functions as a Receptor for Tenascin, Fibronectin, and Vitronectin (*) , 1995, The Journal of Biological Chemistry.

[233]  Ken-ichi Matsumoto,et al.  Differential expression of tenascin-C and tenascin-X in human astrocytomas , 1997, Acta Neuropathologica.

[234]  J. Chen,et al.  Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains. , 1996, The Journal of biological chemistry.

[235]  C. Y. Yu,et al.  An Unequal Crossover between the RCCX Modules of the Human MHC Leading to the Presence of a CYP21B Gene and a Tenascin TNXB/TNXA-RP2 Recombinant between C4A and C4B Genes in a Patient with Juvenile Rheumatoid Arthritis , 1999, Experimental and Clinical Immunogenetics.

[236]  M. Kusakabe,et al.  Identification and immunohistochemical localization of annexin II in rat cornea. , 1999, Current eye research.

[237]  M. Bissell,et al.  Regulation of gene expression and cell function by extracellular matrix. , 1993, Critical reviews in eukaryotic gene expression.

[238]  James F. Conway,et al.  Three-stranded α-fibrous proteins: the heptad repeat and its implications for structure , 1991 .

[239]  J. Thyberg,et al.  Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells , 1988, The Journal of cell biology.

[240]  R. Doolittle Fibrinogen and fibrin. , 1984, Annual review of biochemistry.

[241]  M. Schachner,et al.  Role for myelin‐associated glycoprotein as a functional tenascin‐R receptor , 1999, Journal of neuroscience research.

[242]  M. Neville,et al.  The Mammary gland : development, regulation, and function , 1987 .

[243]  E. Olson,et al.  Homeodomain protein MHox and MADS protein myocyte enhancer-binding factor-2 converge on a common element in the muscle creatine kinase enhancer. , 1994, The Journal of biological chemistry.

[244]  G. Edelman,et al.  Activation of the cytotactin promoter by the homeobox-containing gene Evx-1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[245]  L. Vaughan,et al.  Tenascin-C Binds Heparin by Its Fibronectin Type III Domain Five (*) , 1995, The Journal of Biological Chemistry.

[246]  Z. Werb,et al.  Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. , 1998, Science.

[247]  Eithne Costello,et al.  Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. , 1994, Oncogene.

[248]  G. Edelman,et al.  A proteoglycan with HNK-1 antigenic determinants is a neuron-associated ligand for cytotactin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[249]  G. Vollmer,et al.  Down-regulation of tenascin expression by antiprogestins during terminal differentiation of rat mammary tumors. , 1992, Cancer research.

[250]  F. Rathjen,et al.  The chicken neural extracellular matrix molecule restrictin: Similarity with EGF-, fibronectin type III-, and fibrinogen-like motifs , 1992, Neuron.

[251]  J. Folkman,et al.  Role of cell shape in growth control , 1978, Nature.

[252]  M. Schachner,et al.  Tenascin-R Is a Functional Modulator of Sodium Channel β Subunits* , 1999, The Journal of Biological Chemistry.

[253]  K. Kairemo,et al.  131I radioconjugated antibodies for the locoregional radioimmunotherapy of high-grade malignant glioma--phase I and II study. , 1999, Acta oncologica.

[254]  G. Phillips,et al.  Domains of tenascin involved in glioma migration. , 1998, Journal of cell science.

[255]  Richard T. Lee,et al.  Induction of Tenascin-C in Cardiac Myocytes by Mechanical Deformation , 1999, The Journal of Biological Chemistry.

[256]  G. Edelman,et al.  Multiple promoter elements differentially regulate the expression of the mouse tenascin gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[257]  R. Tucker,et al.  Tenascin-Y in the Developing and Adult Avian Nervous System , 1999, Developmental Neuroscience.

[258]  M. Braddock,et al.  Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway. , 1998, The Journal of clinical investigation.

[259]  S. Aizawa,et al.  Suppression of hematopoietic activity in tenascin-C-deficient mice. , 1998, Blood.

[260]  W. Halfter,et al.  Induction of tenascin in healing wounds , 1988, The Journal of cell biology.

[261]  H. Erickson,et al.  Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C. , 1997, Journal of cell science.

[262]  P. Maurel,et al.  TAG-1/axonin-1 is a high-affinity ligand of neurocan, phosphacan/protein-tyrosine phosphatase-zeta/beta, and N-CAM. , 1996, The Journal of biological chemistry.

[263]  I. Campbell,et al.  1H NMR assignment and secondary structure of the cell adhesion type III module of fibronectin. , 1992, Biochemistry.

[264]  H. Erickson,et al.  Mitogenic and adhesive effects of tenascin-C on human hematopoietic cells are mediated by various functional domains. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[265]  A. M. Arias,et al.  Interactions among Delta, Serrate and Fringe modulate Notch activity during Drosophila wing development. , 1998, Development.

[266]  I. Virtanen,et al.  Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[267]  M. Karin,et al.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.

[268]  G. Edelman,et al.  Site-restricted expression of cytotactin during development of the chicken embryo , 1986, The Journal of cell biology.

[269]  T. Brümmendorf,et al.  Characterization of functional domains of the tenascin-R (restrictin) polypeptide: cell attachment site, binding with F11, and enhancement of F11-mediated neurite outgrowth by tenascin-R , 1995, The Journal of cell biology.

[270]  R. Fässler,et al.  Mouse Ten-m/Odz Is a New Family of Dimeric Type II Transmembrane Proteins Expressed in Many Tissues , 1999, The Journal of cell biology.

[271]  M. Kusakabe,et al.  Preprotachykinin A and cholecystokinin mRNAs in tenascin-gene knockout mouse brain , 1997, Neuropeptides.

[272]  T. Schulthess,et al.  Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth. , 1997, Journal of cell science.

[273]  H. Erickson,et al.  Binding of Tenascin-C to Soluble Fibronectin and Matrix Fibrils * , 1995, The Journal of Biological Chemistry.

[274]  M. Schachner,et al.  Mice Deficient for Tenascin-R Display Alterations of the Extracellular Matrix and Decreased Axonal Conduction Velocities in the CNS , 1999, The Journal of Neuroscience.

[275]  M. Braddock,et al.  Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[276]  M. Chiquet,et al.  Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis , 1984, The Journal of cell biology.

[277]  J. Gulcher,et al.  Structure of the human hexabrachion (tenascin) gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[278]  M. Reidy,et al.  Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. , 1994, Journal of vascular surgery.

[279]  G. Edelman,et al.  Structural and functional similarities between the promoters for mouse tenascin and chicken cytotactin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[280]  G. Edelman,et al.  Multiple integrins mediate cell attachment to cytotactin/tenascin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[281]  Matthias Chiquet,et al.  Tenascin interferes with fibronectin action , 1988, Cell.

[282]  G. Edelman,et al.  Gene regulation of cell adhesion: a key step in neural morphogenesis 1 Published on the World Wide Web on 4 November 1997. 1 , 1998, Brain Research Reviews.

[283]  M. Bottazzi,et al.  α5β1 Integrin Controls Cyclin D1 Expression by Sustaining Mitogen-activated Protein Kinase Activity in Growth Factor-treated Cells , 1999 .